Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
440 INR | -0.63% | +3.02% | +2.28% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 | 50.41B 605M 824M | Sales 2025 * | 58.96B 708M 964M | Capitalization | 237B 2.85B 3.88B |
---|---|---|---|---|---|
Net income 2024 | 1.61B 19.29M 26.26M | Net income 2025 * | 4.25B 51.09M 69.55M | EV / Sales 2024 | 4.66 x |
Net Debt 2024 | 23.65B 284M 387M | Net Debt 2025 * | 22.35B 268M 366M | EV / Sales 2025 * | 4.4 x |
P/E ratio 2024 |
132
x | P/E ratio 2025 * |
57.2
x | Employees | 5,753 |
Yield 2024 * |
0.3% | Yield 2025 * |
0.33% | Free-Float | 65.39% |
Latest transcript on Laurus Labs Limited
1 day | -0.63% | ||
1 week | +3.02% | ||
Current month | -2.29% | ||
1 month | -0.65% | ||
3 months | +10.08% | ||
6 months | +17.85% | ||
Current year | +2.28% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 63 | 05-09-18 | |
Director of Finance/CFO | - | 06-11-29 | |
S. Srinivasa Rao
COO | Chief Operating Officer | - | 08-04-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 63 | 05-09-18 | |
Director/Board Member | 68 | - | |
Director/Board Member | - | 07-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 440 | -0.63% | 42,906 |
24-05-16 | 442.8 | +1.19% | 57,383 |
24-05-15 | 437.6 | +0.96% | 170,263 |
24-05-14 | 433.4 | +0.07% | 25,503 |
24-05-13 | 433.1 | -0.98% | 23,113 |
Delayed Quote Bombay S.E., May 17, 2024 at 06:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- LAURUSLABS Stock
- 540222 Stock